Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Dexcom Inc (NQ: DXCM )

116.97 -1.92 (-1.61%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,800 Today
Via Benzinga
Dexcom G7 is Now the Most Accurate, Smallest, Easy-to-Use CGM Connected to the Tandem t:slim X2 Insulin Pump
From DexCom, Inc.
Via Business Wire
(DXCM) - Analyzing DexCom's Short Interest
Via Benzinga
Market Whales and Their Recent Bets on DXCM Options
Via Benzinga
DexCom Stock Earns Healthy Relative Strength Rating Upgrade
In a welcome move, medical device maker DexCom stock saw its Relative Strength Rating rise from 70 to 77 on Tuesday. 
Via Investor's Business Daily
Analyst Expectations for DexCom's Future
Via Benzinga
Is NASDAQ:DXCM a Fit for Growth Investing Strategies?
Is DEXCOM INC (NASDAQ:DXCM) suited for growth investing? 
Via Chartmill
Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today
Via Benzinga
1 Stock-Split Stock to Buy Hand Over Fist in December, and 1 to Avoid Like the Plague
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there's a historically cheap outperformer, as well as an industry leader that could... 
Via The Motley Fool
Investing $5,000 in These 3 Stocks Could Make You Rich
Artificial intelligence should be a huge tailwind for all three of these stocks. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
3 Growth Stocks to Buy With $1,000 Right Now
If you're having trouble finding your portfolio's next growth holding, here are three great options to choose from -- or you can choose all three. 
Via The Motley Fool
Looking Into DexCom's Recent Short Interest
Via Benzinga
Is DexCom the Next Big Growth Stock?
It has significant growth drivers in play, but competitors are making inroads too. 
Via The Motley Fool
Industry Comparison: Evaluating DexCom Against Competitors In Health Care Equipment &amp; Supplies Industry
Via Benzinga
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
New medicines for weight loss and diabetes stand to disrupt the competitive scene. 
Via The Motley Fool
3 Stock-Split Stocks Billionaires Are Buying Hand Over Fist
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there are three industry-leading stocks that billionaire investors can't stop buying. 
Via The Motley Fool
2 Stock Split Growth Stocks to Buy and Hold
These companies could continue delivering excellent results long after their most recent stock splits are forgotten. 
Via The Motley Fool
Investing Lesson: Value Drivers
Trends come, trends go. So, how can investors spot the difference between another passing fad and something with real, sustainable value? 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Behind the Scenes of DexCom's Latest Options Trends
Via Benzinga
This Is What Whales Are Betting On DexCom
Via Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Could DexCom Stock Help You Become a Millionaire?
DexCom has achieved strong growth over the years, but there's a big question mark over how strong it will be in the future. 
Via The Motley Fool
Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day
From DexCom, Inc.
Via Business Wire
Novo Nordisk, Eli Lilly Skid — But These Weight-Loss Results Are 'Hard To Ignore'
Patients who took Wegovy for five years had a 70% reduced risk of developing diabetes. 
Via Investor's Business Daily
In the world of growth stocks, NASDAQ:DXCM shines as a value proposition.
NASDAQ:DXCM is not too expensive for the growth it is showing. 
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Earnings Winners Poised to Outperform the Market
Discover three earnings winners that beat estimates and could help you beat the market, too. Which ones will you add to your portfolio? 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.